Page 2 - Cough Syrup

Patchy recovery: How 2022 swung from despair to hope to caution

Even as it grappled with new viruses, the human race hit another milestone

Maiden Pharma cough syrup row: Gambian Parliament seeks legal action

WHO, however, said samples tested in Ghana and Switzerland were found to be contaminated

Gambia panel seeks Indian manufacturer's prosecution for cough syrup deaths

A parliamentary committee in The Gambia has recommended prosecution of an Indian manufacturer of cough syrups suspected of causing the deaths of at least 70 children in the West African country

Maiden Pharma seeks to reopen Sonipat plant after DCGI clearance

Health ministry sources say no immediate plan to allow plant to re-open, it was closed for non-compliance with GMP, not for contamination issues

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"

Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI

'Irreparable damage' to Indian pharma's global image, drug regulator writes to WHO

Flu season starts, but demand for cough-cold meds remains weak

Impact in US among the worst in the past 10 years

Role of Maiden Pharma cough syrups in Gambia kids' deaths not confirmed

Indian Health ministry sources say the Haryana-based drug maker is currently being probed for lapses in good manufacturing practices

Cough syrup deaths in the Gambia serious issue, says WHO chief scientist

Swaminathan was speaking to reporters on Thursday on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here

Cough syrup deaths in Gambia serious issue, says WHO chief scientist

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue. Swaminathan was speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here. A WHO report has linked the death of 66 children in Gambia to four Indian-made cough syrups. "Certainly, the government is in touch with WHO as WHO actually provided the report based on the investigation which was done to prove that it was because of the diethylene glycol contamination. It is a very serious issue and it has to be taken very seriously," said Swaminathan. In India there are central as well as state-level drug regulators and there is a need to harmonize their operations, she said. "There are no mechanisms where regulators of different states can actually work together, do the inspections on each other's products," .

Cough syrup makers see healthy future, say controversies won't dent demand

Pharma industry insiders claimed that most contamination-related problems arise due to solvents

After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups

Nigeria has reportedly circulated the alert across all professional bodies, health care providers and supply chain associates

Several states initiate action over contaminated cough syrup controversy

According to the media reports, Karnataka has directed all drugmakers to test samples of glycerine and propylene glycol and submit a report within seven days.

Best of BS Opinion: Beyond inflation target, lessons from Maiden, and more

Here is the best of Business Standard's opinion pieces for today

EAM talks to Gambian counterpart on kids' death linked to cough syrups

Dr S. Jaishankar spoke to his Gambian counterpart Dr. Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India

Drug regulator halts production at Maiden Pharma's Sonipat unit

Centre forms panel to analyse causal relation between deaths and cough syrups

Govt forms panel to study WHO reports on deaths linked to 4 Indian syrups

The government on Wednesday formed a four-member panel of experts to examine the details and adverse event reports received from the WHO on the deaths of 66 children in The Gambia being linked potentially to the four made-in-India cough syrups, official sources here said. They said the committee will recommend further course of action to the Drugs Controller General of India (DCGI) after examining and analysing the adverse event reports, causal relationship and all related details already shared by or to be shared by the World Health Organization. The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceuticals while the state drug regulator has asked it to explain within a week "many contraventions" found during a recent inspection, or face suspension or cancellation of license. The order to halt production came days after the WHO potentially linked four cough syrups manufactured at the facility to the ...

Haryana stops production at plant making cough syrups flagged by WHO

12 violations found at Maiden Pharmaceuticals' Sonipat facility, says state health minister

Preliminary report suggests lapse in manufacturing process at Maiden Pharma

The firm has been in news for supplying contaminated cough syrups to Gambia, which is linked to the deaths of 66 children due to the presence of contaminants

Gambia police link child deaths to cough syrup imported by US firm

The deaths of 69 children from acute kidney injury in Gambia is linked to four cough syrups made in India and imported into the West African country via a US-based pharma firm, the Gambian police said